GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $6,000 | +200.0% | 171 | -80.0% | 0.00% | – |
Q4 2017 | $2,000 | -94.1% | 856 | 0.0% | 0.00% | -100.0% |
Q3 2017 | $34,000 | -5.6% | 856 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $36,000 | 0.0% | 856 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $36,000 | +12.5% | 856 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $32,000 | -27.3% | 856 | -16.2% | 0.00% | 0.0% |
Q3 2016 | $44,000 | 0.0% | 1,021 | 0.0% | 0.00% | -33.3% |
Q2 2016 | $44,000 | +7.3% | 1,021 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $41,000 | 0.0% | 1,021 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $41,000 | +583.3% | 1,021 | +518.8% | 0.00% | – |
Q3 2015 | $6,000 | 0.0% | 165 | 0.0% | 0.00% | – |
Q2 2015 | $6,000 | -14.3% | 165 | 0.0% | 0.00% | – |
Q1 2015 | $7,000 | 0.0% | 165 | 0.0% | 0.00% | – |
Q4 2014 | $7,000 | -99.6% | 165 | -99.5% | 0.00% | -100.0% |
Q4 2013 | $1,938,000 | +6.4% | 36,300 | 0.0% | 0.15% | -9.9% |
Q3 2013 | $1,821,000 | -99.9% | 36,300 | 0.0% | 0.17% | -65.5% |
Q2 2013 | $1,813,911,000 | – | 36,300 | – | 0.50% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |